The PE Ratio as of September 2024 (TTM) for Unity Biotechnology, Inc. (UBX) is -0.73

According to Unity Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.73. This represents a change of -36.33% compared to the average of -1.15 of the last 4 quarters.

Unity Biotechnology, Inc. (UBX) Historical PE Ratio (quarterly & annually)

How has UBX PE Ratio performed in the past?

The mean historical PE Ratio of Unity Biotechnology, Inc. over the last ten years is -2.35. The current -0.73 PE Ratio has changed 3.01% with respect to the historical average. Over the past ten years (40 quarters), UBX's PE Ratio was at its highest in in the March 2023 quarter at -0.48. The PE Ratio was at its lowest in in the December 2017 quarter at -13.91.

Unity Biotechnology, Inc. (UBX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Unity Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unity Biotechnology, Inc. (UBX) Average PE Ratio

How has UBX PE Ratio performed in the past?

The current PE Ratio of Unity Biotechnology, Inc. (UBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Unity Biotechnology, Inc. (UBX) PE Ratio vs. Peers

How is UBX’s PE Ratio compared to its peers?

Unity Biotechnology, Inc.’s PE Ratio is greater than Exscientia plc (-3.76), greater than Recursion Pharmaceuticals, Inc. (-4.26), greater than Atea Pharmaceuticals, Inc. (-1.86), greater than Icosavax, Inc. (-8.27), greater than HOOKIPA Pharma Inc. (-1.28), greater than Acumen Pharmaceuticals, Inc. (-2.36), greater than Heron Therapeutics, Inc. (-5.95), less than Homology Medicines, Inc. (-0.01), greater than Avidity Biosciences, Inc. (-17.71), greater than Beam Therapeutics Inc. (-14.87), greater than Intellia Therapeutics, Inc. (-4.10), greater than Editas Medicine, Inc. (-1.63), greater than Verve Therapeutics, Inc. (-2.42), greater than Prime Medicine, Inc. (-2.04), less than Windtree Therapeutics, Inc. (-0.16), less than Dermata Therapeutics, Inc. (-0.15), less than Ensysce Biosciences, Inc. (-0.27), less than Panbela Therapeutics, Inc. (-0.06), less than Baudax Bio, Inc. (-0.21), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than Nuvation Bio Inc. (-1.47), greater than Ovid Therapeutics Inc. (-2.72), less than NextCure, Inc. (-0.59), greater than Connect Biopharma Holdings Limited (-2.86),

Build a custom stock screener for Unity Biotechnology, Inc. (UBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unity Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unity Biotechnology, Inc. (UBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unity Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.